Loïc Guillevin Selected Research

Microscopic Polyangiitis

1/2022	Evaluation of Rituximab for Induction and Maintenance Therapy in Patients 75 Years and Older With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
1/2022	Kidney Histopathology Can Predict Kidney Function in ANCA-Associated Vasculitides with Acute Kidney Injury Treated with Plasma Exchanges.
12/2020	French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides).
10/2020	ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission induction and maintenance.
1/2020	Microscopic polyangiitis: Clinical characteristics and long-term outcomes of 378 patients from the French Vasculitis Study Group Registry.
1/2020	Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Trial.
3/2019	Cost-effectiveness of rituximab versus azathioprine for maintenance treatment in antineutrophil cytoplasmic antibody-associated vasculitis.
1/2018	Characteristics, outcome and treatments with cranial pachymeningitis: A multicenter French retrospective study of 60 patients.
1/2018	Long-term efficacy of remission-maintenance regimens for ANCA-associated vasculitides.
1/2018	Comparison of individually tailored versus fixed-schedule rituximab regimen to maintain ANCA-associated vasculitis remission: results of a multicentre, randomised controlled, phase III trial (MAINRITSAN2).

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Loïc Guillevin Research Topics

Disease

101	Vasculitis (Vasculitides) 01/2022 - 02/2002
51	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 08/2022 - 04/2003
39	Microscopic Polyangiitis 01/2022 - 02/2003
36	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 10/2022 - 05/2007
34	Churg-Strauss Syndrome (Allergic Angiitis) 01/2021 - 04/2003
23	Infections 01/2022 - 12/2002
21	Systemic Scleroderma (Systemic Sclerosis) 01/2020 - 05/2002
20	Polyarteritis Nodosa (Periarteritis Nodosa) 01/2022 - 02/2002
16	Asthma (Bronchial Asthma) 01/2021 - 10/2004
16	Systemic Vasculitis 12/2020 - 04/2003
11	Glomerulonephritis 10/2022 - 04/2003
11	Inflammation (Inflammations) 01/2019 - 07/2005
10	Neoplasms (Cancer) 01/2020 - 05/2003
10	Hemorrhage 01/2020 - 04/2007
10	Autoimmune Diseases (Autoimmune Disease) 11/2019 - 12/2005
9	Giant Cell Arteritis (Horton Disease) 01/2021 - 06/2011
8	Eosinophilia 01/2017 - 10/2004
7	Renal Insufficiency (Renal Failure) 01/2021 - 05/2006
7	Mononeuropathies (Mononeuritis Multiplex) 10/2020 - 12/2007
7	Cryoglobulinemia 07/2013 - 02/2002
6	Arthralgia (Joint Pain) 01/2022 - 12/2007
6	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 11/2005
6	Necrosis 04/2014 - 11/2005
5	Cardiomyopathies (Cardiomyopathy) 01/2022 - 01/2007
4	Muscular Diseases (Myopathy) 01/2020 - 05/2006
4	Lymphoma (Lymphomas) 01/2018 - 05/2003
4	Pulmonary Arterial Hypertension 08/2016 - 05/2008
4	Rheumatoid Arthritis 07/2013 - 02/2007
4	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2012 - 02/2003
4	Myositis (Idiopathic Inflammatory Myopathies) 01/2011 - 04/2007
4	Fever (Fevers) 11/2010 - 11/2005
4	Acquired Immunodeficiency Syndrome (AIDS) 04/2007 - 02/2002
3	IgA Vasculitis (Purpura, Schoenlein Henoch) 05/2022 - 07/2015
3	Pathologic Constriction (Stenosis) 01/2022 - 03/2012
3	Purpura 01/2022 - 07/2015
3	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2020 - 10/2002
3	Takayasu Arteritis (Arteritis, Takayasu's) 01/2018 - 05/2012
3	Sarcoidosis (Schaumann Disease) 01/2018 - 10/2002
3	Pathologic Complete Response 01/2018 - 11/2014
3	Chronic Kidney Failure (Chronic Renal Failure) 05/2016 - 10/2005
3	Nephritis 03/2016 - 12/2010
3	Lupus Nephritis 03/2016 - 12/2010
3	Thrombosis (Thrombus) 06/2015 - 01/2005
3	Dermatomyositis (Dermatopolymyositis) 10/2014 - 06/2007
3	Carcinoma (Carcinomatosis) 02/2014 - 05/2003
3	Familial Primary Pulmonary Hypertension 06/2012 - 06/2002
3	Diffuse Scleroderma (Progressive Systemic Sclerosis) 01/2012 - 06/2004
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2011 - 01/2005
3	Virus Diseases (Viral Diseases) 01/2011 - 02/2003
3	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2008 - 12/2006

Drug/Important Bio-Agent (IBA)

77	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 10/2004
41	AntibodiesIBA 12/2020 - 07/2004
38	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2020 - 02/2003
31	Rituximab (Mabthera)FDA Link 10/2022 - 05/2006
29	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 04/2003
22	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020 - 06/2002
21	GlucocorticoidsIBA 10/2022 - 02/2003
15	Biological ProductsIBA 10/2020 - 02/2003
15	AutoantibodiesIBA 03/2015 - 11/2003
14	AntigensIBA 07/2014 - 11/2003
13	Azathioprine (Imuran)FDA LinkGeneric 03/2019 - 02/2008
12	Peroxidase (Myeloperoxidase)IBA 01/2022 - 10/2004
10	Intravenous Immunoglobulins (IVIG)FDA Link 01/2020 - 06/2005
10	Myeloblastin (Proteinase 3)IBA 01/2019 - 05/2007
10	Immunoglobulin G (IgG)IBA 01/2018 - 12/2002
8	CreatinineIBA 01/2022 - 10/2005
8	Antiviral Agents (Antivirals)IBA 05/2016 - 02/2002
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2007
7	SteroidsIBA 11/2017 - 04/2003
6	Pharmaceutical PreparationsIBA 01/2022 - 04/2005
5	CytokinesIBA 05/2022 - 12/2006
5	tocilizumab (atlizumab)FDA Link 01/2021 - 07/2013
5	Antigen-Antibody Complex (Immune Complex)IBA 01/2018 - 09/2005
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2015 - 10/2004
5	Cytotoxins (Cytolysins)IBA 10/2012 - 02/2002
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2014
4	Peptide Hydrolases (Proteases)FDA Link 01/2019 - 01/2005
4	Monoclonal AntibodiesIBA 01/2016 - 02/2007
4	Prednisone (Sone)FDA LinkGeneric 01/2016 - 10/2004
4	Infliximab (Remicade)FDA Link 06/2015 - 07/2005
4	Immunoglobulin M (IgM)IBA 01/2012 - 11/2003
4	Interferon-alpha (Interferon Alfa)IBA 01/2011 - 12/2002
4	DNA (Deoxyribonucleic Acid)IBA 09/2008 - 01/2004
3	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 12/2008
3	Hemoglobins (Hemoglobin)IBA 01/2021 - 04/2013
3	mepolizumabIBA 06/2018 - 07/2013
3	Mycophenolic Acid (Cellcept)FDA LinkGeneric 03/2016 - 12/2010
3	anti-IgE antibodiesIBA 01/2016 - 02/2007
3	AutoantigensIBA 09/2012 - 08/2007
3	Influenza Vaccines (Influenza Vaccine)FDA Link 04/2012 - 03/2011
3	VaccinesIBA 01/2012 - 03/2011
3	Anti-Bacterial Agents (Antibiotics)IBA 10/2011 - 10/2003
3	C-Reactive ProteinIBA 11/2010 - 06/2007
3	ametantrone (HAQ)IBA 09/2010 - 02/2007

Therapy/Procedure

46	Therapeutics 10/2022 - 06/2002
16	Plasma Exchange 10/2022 - 02/2002
8	Biological Therapy 10/2020 - 02/2007
5	Remission Induction 10/2020 - 05/2014
3	Aftercare (After-Treatment) 01/2021 - 09/2005
3	Transplantation 05/2016 - 07/2004